Emerging Technologies

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.

Boston Children’s, CVS, Geisinger, UC San Diego and Wellspan are among the 28 providers and payers promising their AI and machine learning models are geared to ensure healthcare outcomes that are "Fair, Appropriate, Valid, Effective and Safe."  

The two models of MedLM are built on the tech giant's medical LLM Med-PaLM 2, with one designed for complex tasks and the other for scaling across various tasks.

Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.

The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.

Rock Health's Digital Health at the Turn of 2024 report found retailers as providers and data interoperability are scaling innovations in the sector, with lasting trajectories.

The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.

Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.

The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.

Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.